U.S. FDA clears Pfizer’s COVID-19 booster shot for 12- to 15-year-olds

Published by

(Reuters) – The U.S. Food and Drug Administration on Monday authorized the use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children aged between 12 and 15 years. (Reporting by Ankur Banerjee and Manas Mishra in Bengaluru)

Read More

Leave a Reply